2022 – Page 2 – Policy & Medicine

DOJ Announces $45 Million Settlement with EHR Vendor Over False Claims Act Violations

DOJ and OIG Turn Focus to Corporate Integrity Agreements

Providers Call on Congress to Extend APM Incentive Payments

DOJ Continues to Prosecute False Claims Act Cases

Who Does the 340B Program Benefit?

Do Private Equity Acquisitions Increase Healthcare Spending and Patient Utilization?

DOJ Announces Nearly $8 Million Settlement with Akorn, Resolving False Claims Act Allegations

New England Dermatology Office Fined for Improper PHI Disclosure

2023 Medicare Physician Fee Schedule Released

How Clinical Care Options Met Healthcare Professionals’ Needs in Real Time During the COVID-19 Pandemic